Daré Bioscience Announces Grant Award Of ~$385,000 Supporting Development Of Potential New Therapeutic Intervention For The Prevention Of Idiopathic Preterm Birth
Portfolio Pulse from Happy Mohamed
Daré Bioscience, Inc. (NASDAQ:DARE) has been awarded a grant of approximately $385,000 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH). The grant will support the development of a potential new therapeutic intervention for the prevention and treatment of idiopathic preterm birth. Daré will collaborate with the Lockwood Laboratory at the University of South Florida (USF) Morsani College of Medicine on the grant-funded activities.
July 31, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The grant award to Daré Bioscience for the development of a potential new therapeutic intervention for preterm birth prevention and treatment could boost the company's research and development efforts and potentially lead to a new product offering.
The grant award will support Daré Bioscience's research and development efforts in a critical area of unmet need - the prevention and treatment of idiopathic preterm birth. This could potentially lead to the development of a new product offering, which could have a positive impact on the company's future revenues and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100